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The Influence of Both Urea and 2,2,2-Trifluoroethanol in the Amyloid
Fibril Formation of Bovine Serum Albumin
Lenilson T. Brito, Leandro R.S. Barbosa.
Instituto de Fı´sica da USP, Sao Paulo, Brazil.
The influence of external agents on proteins function and structure is essential
to elucidate the unfolding pathways and self-assemble properties. The knowl-
edge of the protein amyloid fibril formation process is important due to the
fields that this subjected is related, in particular for the neurodegenerative
disorders. In the present work we studied the influence of both urea and
2,2,2-Trifluoroethanol (TFE) and temperature on the structure and protein-
protein interactions of Bovine Serum Albumin (BSA), by means of UV-Vis
spectroscopy, static fluorescence and small angle X-ray scattering technique.
The experiments were performed in samples composed by 10 and 3 mg/ml of
BSA at pH 5.8, near the protein pI. First, Thioflavin-T fluorescence measure-
ments indicated that urea, in the absence of TFE, was able to increase the
amyloid fibril formation of BSA at 45oC and increasing the urea concentra-
tion the rate of amyloid fibril formation also increases. Concerning the pres-
ence of TFE, SAXS data suggest that BSA tridimensional structure is not
altered by the presence of TFE 5% and 10% v/v in all studied protein concen-
trations. Interestingly, the presence of TFE on the urea-containing BSA also
increases the rate of amyloid fibril formation, as compared to the TFE-free
system, indicating that TFE can catalyze the amyloid-fibril formation. The
presence of TFE 20% v/v, however, induces the formation of aggregates,
but at this time we were not able to infer if such aggregates are amyloid-
like or amorphous. Taking together, the results give support to infer that
BSA can for fibrils in the presence of urea at 45oC and TFE can act as a sta-
bilizer or as a denaturant agent for BSA.
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Human Lysozyme Amyloidosis: MD Simulations Reveal Increased Struc-
tural Destabilization in Disease causing Mutants Compared to Wildtype
Mattaparthi V. Satish Kumar1, Rajaram Swaminathan2.
1SASTRA University, Thanjavur, India, 2Indian Institute of Technology
Guwahati, Guwahati, India.
D67H and I56T are the two known natural mutants of human lysozyme
caused by autosomal dominant gene mutations. They both cause hereditary
systemic nonneuropathic amyloidosis, a condition symptomatic with deposi-
tion of human lysozyme amyloid fibrils (sometimes in kilogram quantities) in
the kidneys, gastrointestinal tract, lymph nodes, blood vessels, spleen and
liver of patients [Pepys et. al., Nature, 362, 553-557 (1993)]. The structural
features of species formed early during the aggregation process, which trig-
ger amyloidosis, appear important to investigate. In this study, we have com-
pared the conformational dynamics of wild type and mutants of human
lysozyme (D67H, I56T, and T70N) using all atom MD simulations under na-
tive conditions. All the four simulations (20 ns each) were performed using
ff99SB Amber force field to investigate the conformational dynamics. We
have analyzed the trajectories arising from these simulations to obtain in-
sights on conformational features triggering amyloidosis. The analyses of
backbone RMSD, B factor values, SASA, end to end chain distance, second-
ary structure content, distance matrix, S2 order values, conformational en-
tropy, water movement around residues in core domain and hydrophobic
contacts all reveal greater structural destabilization in mutants in comparison
to wild type human lysozyme. The higher b content in secondary structure,
increased flexibility and disruption in hydrophobic contacts near the a/b do-
main interface and in b domain in I56T and D67H mutants perhaps leads to
their amyloidogenicity. Our results also hint that Y38 residue at the hydro-
phobic core (near the a/b domain interface) to be the seed for fibril formation
in mutants.
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Can Melatonin Help Prevent Alzheimer’s Disease?
Katherine Clausen.
DePaul, Chicago, IL, USA.
In previous studies, the orthomolecular species melatonin has been found to
have a tremendous impact on the b-amyloid peptide that causes Alzheimer’s
disease. Melatonin has been shown to inhibit oxidative stress and the death
of neurons and neuroblastoma cells exposed to the peptide. The purpose of re-
search on an orthomolecular species such as melatonin is to determine how thechemical substance reacts with a disease or abnormality by restoring proper
levels of the chemical substance in the brain. The first step in the process of re-
searching the effects of melatonin on the Alzheimer’s b-amyloid peptide is to
make melatonin water soluble. Studies suggest that melatonin powder can be-
come water soluble when mixed with water at 20 C or 50 C. Studies have also
shown that melatonin is soluble in ethanol. This study utilized all three tech-
niques to create melatonin solutions. Melatonin in a fine powder was added
to water at 20 C , water at 50 C , and ethanol at 20 C. All three solutions
were centrifuged to gather only the water soluble aspects of the melatonin so-
lutions. The melatonin concentration of each solution was determined using
a calibration curve. The calibration curve was created using a UV/vis machine
to measure the absorbances of serially diluted solutions with known concentra-
tions made from pure melatonin. The presence of melatonin in each solution
was confirmed using ATR-IR spectroscopy by comparing spectra of each
solution to a melatonin reference spectra. Each solution was combined with
b-amyloid peptide and Congo red and measured in the UV/vis for a week.
Each solution was combined with the b-amyloid peptide and measured with
ATR-IR for a week. The data was then analyzed and compared to solutions
with b-amyloid peptide and no melatonin.
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Effects of Silymarin on Ab Fibrillization of Alzheimer’s Disease
Luke R. Mockaitis.
DePaul University, Chicago, IL, USA.
In recent years, research has begun to be conducted on the effects that the
compound Silymarin, a component of milk thistle and a current treatment
for liver ailments, jaundice, and prostate cancer, has on the neurodegenerative
disease of Alzheimer’s. These studies have shown promising results with uti-
lizing Silymarin as both a preventative and protecting agent against various
neurodegenerative diseases. The aim of this current research is to further
examine these possible effects on formation of fibrils in the brains of those
afflicted by Alzheimer’s. We aim to examine if this compound has any effect
at either slowing or stopping the formation of fibrils all together and if so to
what extent.
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Using a Peptide System to test the Coiled-Coil Model of Polyglutamine
Aggregation
Bashkim Kokona, Karl A. Johnson, Robert Fairman.
Haverford College, Haverford, PA, USA.
We test a recent hypothesis from the literature that proposes a role for helical
interactions in polyglutamine aggregation. We use as our model system a pep-
tide sequence based on the GCN4-pLI parallel coiled-coil tetramer, with lysines
at all e and c heptad positions, fused to a short polyglutamine of 25 residues.
The coiled-coil sequence will bind preferentially to a second peptide, ecE,
which contains glutamates at the same e and c heptad positions, to form a stable
tetramer. using CD, FTIR, and DLS methods, we show that the lysine-
containing peptide, ecK-Q25KK, when studied alone, shows a significant de-
crease in aggregation kinetics when compared to a control peptide, KKQ25KK.
We show that ecK-Q25KK aggregates via a coiled-coil rich intermediate over
a period of a week, and then transitions to a cross beta-sheet conformation after
an additional week. Such a transition is not observed when ecE peptide is pres-
ent, presumably due to increased stabilization of the coiled-coil conformation.
We added a proline-containing linker between the coiled-coil sequence and the
polyQ sequence to test whether inhibition of helix propagation would influence
the kinetics of this assembly reaction. We found that the addition of the linker
significantly slowed down the assembly kinetics. We also studied the morphol-
ogy of the resultant fibrils, using AFM and TEM, and found that the fibrils are
quite similar to those observed previously for the KKQ25KK model system.
Our results are surprising since the natural N-terminal sequence from the hun-
tingtin protein significantly accelerates beta-sheet aggregation, also in a model
involving coiled-coil interactions. The difference in our results from these ear-
lier experiments may lie in the stability of the coiled-coil interactions, with our
coiled-coil sequence (28 residues) being longer than that found in the hunting-
tin sequence (17 residues).
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Structural Basis for Ternary Complex Formation between Tau, Hsp90,
and FKBP51
Alexander Barrett, Hongwei Wu, Stepan Kashtanov, Gary Daughdrill.
University of South Florida, Tampa, FL, USA.
The normal function of the microtubule associated protein tau is to bind and
stabilize microtubules (MT) via its C-terminal assembly domain. When tau
dissociates from MTs it can be phosphorylated and targeted for proteasomal
degradation. Hyperphosphorylated forms of tau can form aggregates that
are thought to be toxic in Alzheimer’s Disease. The molecular chaperone
